Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04403204 · ClinicalTrials.gov registry record
ICG Fluorescence Imaging in Post-traumatic Infection
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 104
- Enrollment target
NCT04403204: Completed study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT04403204 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04403204 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
Study Summary
The focus of this prospective observational study is to (1) establish the range and variation associated with bone/soft tissue perfusion in fracture patients, using ICG fluorescence imaging; (2) examine the relationship between perfusion and complications such as surgical site infection (SSI), persistent SSI, and fracture nonunion; (3) to determine whether the quantitative ICG fluorescence can be used to guide bony debridement in the setting of infected fracture to minimize complications.
Primary Outcome
Post-procedure surgical site infection using CDC criteria will be documented at each follow-up appointment up to one year
Interventions
- OTHER Immunofluorescence Imaging
- OTHER DCE-MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2020-09-14 |
| Est. Completion | 2025-10-08 |
What the finished NCT04403204 record still lists
NCT04403204 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Immunofluorescence Imaging is the first listed.
NCT04403204 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04403204 about?
NCT04403204 is a clinical study titled "ICG Fluorescence Imaging in Post-traumatic Infection". The focus of this prospective observational study is to (1) establish the range and variation associated with bone/soft tissue perfusion in fracture patients, using ICG fluorescence imaging; (2) examine the relationship between perfusion and complications such as surgical site infection (SSI), persi...
What is the current status of trial NCT04403204?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2020-09-14. Estimated completion is 2025-10-08.
What interventions are being tested in trial NCT04403204?
The interventions under investigation include: Immunofluorescence Imaging (OTHER), DCE-MRI (OTHER).
Who is sponsoring clinical trial NCT04403204?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI